REG - Eden Research plc - Appointment of Auditor

Eden ResearchAnnouncement

28/09/2022 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220928:nRSb9772Aa&default-theme=true

RNS Number : 9772A  Eden Research plc  28 September 2022

28 September 2022

Eden Research Plc

("Eden" or "Company")

Change of Auditor

Eden Research plc (AIM: EDEN; OTCQB:  EDNSF), the AIM-quoted company focused
on sustainable biopesticides and plastic-free formulation technology for use
in the global crop protection, animal health and consumer products industries,
today announces that, following a competitive and comprehensive tender
process, PKF Littlejohn LLP ("PKF") has been appointed as the Company's
auditor for the year ending 31 December 2022. The Company intends to put the
appointment of PKF as auditor to a vote of shareholders at the Company's next
Annual General Meeting.

Following the tender process and the decision to appoint PKF, KPMG UK LLP
("KPMG") has resigned. The Board wishes to take this opportunity to extend
appreciation to KPMG for its services rendered to the Company.

As required by section 519 of the Companies Act 2006, KPMG has deposited a
statement with the Company confirming that there are no circumstances in
connection with its resignation as auditor that should be brought to the
attention of the Company's shareholders and the reason for their resignation
was as a result of its fees no longer being acceptable to the Company.

 

For further information, contact:

 

 Eden Research plc                               www.edenresearch.com

 Sean Smith                                      01285 359 555

 Alex Abrey

 Cenkos Securities (NOMAD and broker)            020 7397 8900

 Giles Balleny / Max Gould (Corporate Finance)

 Michael Johnson (Sales)

 Hawthorn Advisors                               eden@hawthornadvisors.com

 Stephen Atkinson

 Victoria Ainsworth

 

Notes to Editors:

 

Eden Research is the only UK-listed company focused on biopesticides for
sustainable agriculture. It develops and supplies innovative biopesticide
products and natural microencapsulation technologies to the global crop
protection, animal health and consumer products industries.

 

Eden's products are formulated with terpene active ingredients, based on
natural plant defence metabolites. To date, they have been primarily used on
high-value fruits and vegetables, improving crop yields and marketability,
with equal or better performance when compared with conventional pesticides.
Eden has two products currently on the market:

 

Based on plant-derived active ingredients, Mevalone® is a foliar
biofungicide which initially targets a key disease affecting grapes and other
high-value fruit and vegetable crops.  It is a useful tool in crop defence
programmes and is aligned with the requirements of integrated pest management
programmes. It is approved for sale in a number of key countries whilst Eden
and its partners pursue regulatory clearance in new territories thereby
growing Eden's addressable market globally.

 

Cedroz™( )is a bio-nematicide that targets free living nematodes which are
parasitic worms that affect a wide range of high-value fruit and vegetable
crops globally. Cedroz is registered for sale on two continents and Eden's
commercial collaborator, Eastman Chemical, is pursuing registration and
commercialisation of this important new product in numerous countries
globally.

 

Eden's Sustaine(®)( )encapsulation technology is used to harness the
biocidal efficacy of naturally occurring chemicals produced by plants
(terpenes) and can also be used with both natural and synthetic compounds to
enhance their performance and ease-of-use. Sustaine microcapsules are
naturally-derived, plastic-free, biodegradable micro-spheres derived from
yeast. It is one of the only viable, proven and immediately registerable
solutions to the microplastics problem in formulations requiring
encapsulation.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the
symbol EDEN. It was awarded the London Stock Exchange Green Economy
Mark in January 2021, which recognises London-listed companies that derive
over 50% of their total annual revenue from products and services that
contribute to the global green economy. Eden derives 100% of its total annual
revenues from sustainable products and services.

 

For more information about Eden, please visit:  www.edenresearch.com
(http://www.edenresearch.com/) .

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPEAXNPALSAEEA